SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $14,504 | $24,615 | $132,467 |
| Gross Profit | $0 | -$14,504 | -$24,615 | -$132,467 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,357,000 | $2,849,590 | $6,118,125 | $4,955,385 |
| G&A Expenses | $0 | $0 | $1,781,183 | $1,665,498 |
| SG&A Expenses | $1,159,000 | $1,675,635 | $1,781,183 | $1,665,498 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,516,000 | $4,525,225 | $7,899,308 | $6,620,883 |
| Operating Income | -$3,516,000 | -$4,539,729 | -$7,899,308 | -$6,620,884 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $507,000 | $1,997,594 | $3,201,557 | $2,060,461 |
| Pre-Tax Income | -$3,009,000 | -$2,542,135 | -$4,697,443 | -$4,560,423 |
| Tax Expense | $127,000 | $102,196 | $862,141 | $117,433 |
| Net Income | -$2,882,000 | -$2,644,332 | -$5,559,584 | -$4,677,856 |
| % Margin | – | – | – | – |
| EPS | -41.85 | -40.48 | -95.99 | -90.33 |
| % Growth | -3.4% | 57.8% | -6.3% | – |
| EPS Diluted | -41.85 | -40.48 | -95.99 | -90.33 |
| Weighted Avg Shares Out | 68,866 | 65,323 | 57,918 | 51,789 |
| Weighted Avg Shares Out Dil | 68,866 | 65,323 | 57,918 | 51,789 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,465 | $4,010 | $2,240 |
| Interest Expense | $6,000 | $25,813 | $25,270 | $44,606 |
| Depreciation & Amortization | $9,000 | $14,000 | $24,615 | $132,467 |
| EBITDA | -$3,507,000 | -$4,525,225 | -$4,648,983 | -$4,383,350 |
| % Margin | – | – | – | – |